Increasing the CTC detection sensitivity through FETCH technology

• Conditions: Prostate cancer - Breast cancer; 10006291

• Registration Number: NL-OMON53301
• Lead Sponsor: niversiteit Twente

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

Diagnosed metastatic breast cancer OR metastatic castration resistant prostate
cancer
A planned blood collection
At least 18 years of age

Exclusion Criteria

No informed consent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The number of CTC found for each of the two methods. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Number of healthy cells co-captured using the two tested methods. </p><br>